View Press Releases
-
Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
SHIRLEY, NY - Aug 12, 2019 - It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy
Aug 12, 2019
-
Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
HOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDA
Aug 8, 2019
-
WCG Acquires PharmaSeek, LLC
PRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites
Aug 8, 2019
-
Shimmer Wins Two GHP International Life Sciences Awards for its Wearable Sensor Technology
CAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019
Aug 7, 2019
-
BioIVT to Host Symposium Highlighting Industry Progress in Immuno-oncology Drug Discovery Research
WESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on Aug
Aug 7, 2019
-
LabTwin Partners with CA-based Biotech Shared Laboratory Community and Incubator; Bonneville Labs and Lab Launch Give Biotech Startups Access to World’s First Voice and AI-Powered Digital Lab Assistan
BERLIN, GERMANY - Jul 30, 2019 - LabTwin GmbH, the worlds first voice and AI-powered digital lab assistant, today announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch
Aug 6, 2019
-
Certara Launches BaseCase Data Manager to Enhance Value-based Customer Presentations
PRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population data
Aug 6, 2019
-
BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens
WESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc
Aug 6, 2019
-
Wisconsin State Laboratory Adopts Quantabio Products to Improve Newborn Screening for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
BEVERLY, MA, UNITED STATES - Aug 5, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the Wisconsin State Laboratory of Hygiene has adopted its technology to improve newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID)
Aug 5, 2019
-
Signant Health Senior Vice President Dr. David Daniel Honored in PharmaVOICE 100
PLYMOUTH MEETING, PA - Aug 1, 2019 - Signant Health (formerly CRF Health and Bracket) today announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector
Aug 1, 2019
-
BINDING SITE OFFERS ANTIGENS & ANTIBODIES WITH EMPHASIS ON HUMAN COAGULATION APPLICATIONS
SAN DIEGO, CA - Jul 31, 2019 - San Diego, CA . . . . Binding Sites IMMUNOLOGICALS GROUP is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation testing applications
Jul 31, 2019
-
BetterPT and BlueJay Mobile Health Announce Partnership to Expand Connectivity Between Patients, Physical Therapists and Healthcare Providers
NEW YORK, NY - Jul 30, 2019 - BetterPT, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and BlueJay Mobile Health, a full-service mobile technology company transforming healthcare delivery and care team coordination through AI-powered telehealth, today announced a partnership to bridge patients, PTs and healthcare providers through the full continuum of care
Jul 30, 2019
-
OHSU to Become First Health System in Oregon to Implement Kyruus ProviderMatch®
BOSTON, MA, UNITED STATES - Jul 30, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OHSU in Portland, Oregon, a nationally distinguished research organization, will utilize the Kyruus ProviderMatch® platform to enhance patient access to providers and services across the OHSU health system
Jul 30, 2019
-
MR Solutions receives a Third Queen’s Award for innovative PET imaging technology in pre-clinical scanners
GUILDFORD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queens Award for Enterprise in recognition of the companys innovative PET imaging technology for use in pre-clinical research
Jul 30, 2019
-
X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome
CAMBRIDGE, MA, US - Jul 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the European Commission (EC), based on a favorable recommendation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation (ODD) to mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease caused by genetic mutations in the CXCR4 receptor gene
Jul 30, 2019
-
Trinity Cyber Secures $23 Million in Funding, Led by Intel Capital, to Redefine Cybersecurity by Proactively Disrupting Cyber Attacks
BOWIE, MD - Jul 30, 2019 - Start-up Trinity Cyber achieved a major milestone with its closure today on $23 million in funding from top institutional investors led by Intel Capital
Jul 30, 2019
-
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform
PRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19
Jul 30, 2019
-
BOC Sciences Offers Inhibitor Eribulin for Breast Cancer Research
SHIRLEY, NY, NY, UNITED STATES - Jul 30, 2019 - The world's leading chemical vendor BOC Sciences announces at its headquarter in New York to release a featuring inhibitor chemical – eribulin – for researchers who are involved with breast cancer research in the pharmaceutical industry
Jul 29, 2019
-
Microway Appoints Lorne Wilson as COO
PLYMOUTH, MA - Jul 29, 2019 - Microway Appoints Lorne Wilson as COOExperienced IT executive to lead company operations toward continued growth Microway, a leading provider of fully integrated and validated computational clusters, servers, and workstations for AI and HPC, announces the appointment of Lorne Wilson as Chief Operating Officer
Jul 29, 2019
-
TrialScope Taps Industry Veteran as CTO
BURLINGTON, NJ, UNITED STATES - Jul 29, 2019 - TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer
Jul 29, 2019